Q2 2024

Filed Aug 26, 2024 · 10-Q · 57 days after period end · 0001410578-24-001560

Q2 2024 · 10-Q

Revenue

$254.00K

no prior Q2 2023 on file

Net Income

-$5.73M

no prior Q2 2023 on file

EPS Diluted

-$7.35

no prior Q2 2023 on file

Operating Income-$6,659,000—

Operating Cash Flow

Same quarter

no prior Q2 2023 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2024 · filed Aug 26, 2024 · 57 d after period end

Adagio Medical Holdings, Inc. · CIK 2006986 · Engraved from SEC EDGAR